C95.92
C95.92 — Leukemia, unspecified, in relapse
Billable / specific codeICD-10-CM
C95.92 is a billable, specific ICD-10-CM code for leukemia, unspecified, in relapse. It is valid for submission on a claim.
Risk adjustment
C95.92 risk-adjusts. Under the CMS-HCC V28 model it maps to this category:
- HCC 22 Bladder, Colorectal, and Other Cancers0.363 RAF
Coefficient shown for the Community Non-dual Aged segment. A higher HCC in the same hierarchy will suppress this one, so capturing it does not always add score.
Medicare coverage
C95.92 is named in 39 Medicare coverage policies — 37 listing it as supporting medical necessity, and 2 listing it as NOT covered. Which of them applies to you depends on your Medicare contractor, and coverage genuinely differs by state.
- A56462Billing and Coding: Erythropoiesis Stimulating Agents (ESA)not covered
- A60435Billing and Coding: Erythropoiesis Stimulating Agents (ESA)not covered
- A52480Oral Antiemetic Drugs (Replacement for Intravenous Antiemetics) - Policy Article
- A52986Billing and Coding: Biomarkers for Oncology
Related codes at this level
Codes that share C95.9. If C95.92 is not quite right, the correct code is usually one of these.
Questions about C95.92
- Is C95.92 a billable ICD-10-CM code?
- Yes. C95.92 is a billable, specific ICD-10-CM code and is valid for submission on a claim.
- Where does C95.92 sit in the tabular list?
- Neoplasms (C00-D49), in the block Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96).